Dayang Medical Lists on NEEQ After Reporting RMB 67.28 Million Revenue from January to May 2016

Dayang Medical received approval to list on China's National Equities Exchange and Quotations under the securities abbreviation Dayang Medical and stock code 870460, with the listing taking effect on January 20, 2017.

Corporate Milestone

The company's reported operating revenue was RMB 110 million in 2014, RMB 116 million in 2015, and RMB 67.2753 million from January to May 2016. Net profit for the same periods was RMB 1.2448 million, RMB 4.4478 million, and RMB 807,100.

Business Context

Dayang Medical is a high-tech enterprise engaged in the R&D, production, and sales of rehabilitation and nursing products, including wheelchairs, commode chairs, shower chairs, crutches, walkers, nursing beds, and related accessories. Guosen Securities served as the lead brokerage, Beijing Dacheng Law Offices Shenzhen office served as legal adviser, and Daxin Certified Public Accountants served as auditor.